تداخلهای دارویی
Galcanezumab + Rozanolixizumab
شدت: متوسط
Galcanezumab and Rozanolixizumab: moderate interaction.
آخرین بهروزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصهای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمیشود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG from lysosomal degradation. Galcanezumab is an IgG4 antibody, so its concentrations may fall and its migraine-preventive effect may diminish. Clinical data for this combination are lacking.
معنای این تداخل به زبان ساده
Galcanezumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Galcanezumab belongs to Central Nervous System; Rozanolixizumab belongs to Miscellaneous.
چرا رخ میدهد
FcRn blockade by rozanolixizumab shortens the half-life of IgG-based antibodies such as galcanezumab.
اقدام لازم
Monitor migraine control and consider a non-antibody preventive if efficacy declines. Reassess the need for galcanezumab while rozanolixizumab cycles are given.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیههای کامل مدیریت Galcanezumab و Rozanolixizumab، یادداشتهای تکمیلی، جزئیات شواهد و بررسیکننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Galcanezumab
تداخلات دیگر Rozanolixizumab
پرسشهای متداول
Can I take Galcanezumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Galcanezumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG from lysosomal degradation. Galcanezumab is an IgG4 antibody, so its concentrations may fall and its migraine-preventive effect may diminish. Clinical data for this combination are lacking.
How serious is the interaction between Galcanezumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine control and consider a non-antibody preventive if efficacy declines. Reassess the need for galcanezumab while rozanolixizumab cycles are given.
What other medicines interact with Galcanezumab?
MediHelp also lists interactions of Galcanezumab with, for example, Efgartigimod / hyaluronidase sc, Efgartigimod alfa. The full list is on the Galcanezumab page.
تکنگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.